CN110742930A - Rhinitis ointment - Google Patents
Rhinitis ointment Download PDFInfo
- Publication number
- CN110742930A CN110742930A CN201911088094.1A CN201911088094A CN110742930A CN 110742930 A CN110742930 A CN 110742930A CN 201911088094 A CN201911088094 A CN 201911088094A CN 110742930 A CN110742930 A CN 110742930A
- Authority
- CN
- China
- Prior art keywords
- rhinitis
- nasal
- asarum
- cinnabar
- main materials
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/02—Ammonia; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/28—Mercury; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/36—Skin; Hair; Nails; Sebaceous glands; Cerumen; Epidermis; Epithelial cells; Keratinocytes; Langerhans cells; Ectodermal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/19—Acanthaceae (Acanthus family)
- A61K36/195—Strobilanthes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/26—Aristolochiaceae (Birthwort family), e.g. heartleaf
- A61K36/268—Asarum (wild ginger)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
- A61K36/315—Isatis, e.g. Dyer's woad
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/57—Magnoliaceae (Magnolia family)
- A61K36/575—Magnolia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/704—Polygonum, e.g. knotweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
- A61K36/714—Aconitum (monkshood)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Medical Informatics (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Inorganic Chemistry (AREA)
- Otolaryngology (AREA)
- Cell Biology (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Developmental Biology & Embryology (AREA)
- Dermatology (AREA)
- Virology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The application discloses rhinitis ointment, which comprises main materials and auxiliary materials, wherein the main materials comprise salmiacum, biond magnolia flower, asarum, cocklebur fruit, pangolin scales, cinnabar, borneol, indigo naturalis, angelica dahurica, radix aconiti preparata and sodium hydroxide, and the weight percentages of all the components in the main materials are as follows: 10% of sal ammoniac, 8% of magnolia flower, 2% of asarum, 8% of cocklebur fruit, 5% of pangolin scales, 1% of cinnabar, 3% of sliced plum, 5% of indigo naturalis, 15% of angelica dahurica, 10% of prepared radix aconiti and 10% of sodium hydroxide, and the auxiliary materials comprise vaseline. The rhinitis ointment formed by combining the components in the main material can effectively treat acute and chronic rhinitis, hypertrophy of nasal turbinates, nasal polyp, nasosinusitis and other nasal symptoms, and has the effects of obvious treatment effect, high cure rate, short treatment time, low treatment cost and stable drug effect.
Description
Technical Field
The application relates to the technical field of rhinitis treatment, in particular to rhinitis cream.
Background
Rhinitis is a common disease, namely nasal inflammatory disease, and is inflammation of nasal mucosa caused by viruses, bacteria, allergens, various physical and chemical factors and certain systemic diseases. The main pathological changes of rhinitis are congestion, swelling, exudation, hyperplasia, atrophy or necrosis of the nasal mucosa. Especially in the present days that the environmental pollution is more and more serious and the extreme weather is more and more infrequent, the rhinitis patients are more and tend to be in a low age. Rhinitis seems to be a little disease with great harm, and causes great influence on five sense organs of a human body in the disease period, thereby bringing great pain to the work and life of rhinitis patients. Failure to obtain effective treatment for a long period of time can also induce a variety of serious diseases and even be life threatening. The nasopharynx swelling of Jiucheng is caused by the aggravation of rhinitis. Other complications resulting from rhinitis are: emphysema, pulmonary heart disease, asthma, otitis media, meningitis, etc. According to statistics: the patient suffers from sleep apnea syndrome due to long-time stuffy nose, difficult breathing, insufficient oxygen during sleep, cerebral infarction, hypertension, sudden heart disease and the like under severe conditions, and even sudden death at night, which occurs in all hospitals. Allergic rhinitis sensitive to environmental factors often causes patients to sneeze and tear continuously due to dust and cold air, and the normal work, rest and life of the patients are seriously influenced.
At present, a lot of medicines for treating diseases such as rhinitis, nasosinusitis, frontal sinusitis, nasal polyp, hypertrophy of nasal turbinates and the like exist, but most of the medicines have the defects of being not obvious enough in effect, low in cure rate, long in treatment time, high in treatment cost, capable of repeatedly relapsing and the like.
Disclosure of Invention
The embodiment of the application provides rhinitis ointment, which solves the problems of unobvious treatment effect, low cure rate, long treatment time, high treatment cost and unstable drug effect of the existing drugs for treating rhinitis.
In order to solve the technical problem, the present application is implemented as follows:
the rhinitis ointment comprises main materials and auxiliary materials, wherein the main materials comprise sal ammoniac, magnolia flower, asarum, cocklebur fruit, pangolin scales, cinnabar, borneol, indigo naturalis, angelica dahurica, radix aconiti preparata and sodium hydroxide, and the weight percentages of the main materials are as follows: 10% of sal ammoniac, 8% of magnolia flower, 2% of asarum, 8% of cocklebur fruit, 5% of pangolin scales, 1% of cinnabar, 3% of sliced plum, 5% of indigo naturalis, 15% of angelica dahurica, 10% of prepared radix aconiti and 10% of sodium hydroxide, and the auxiliary materials comprise vaseline.
In the embodiment of the application, the rhinitis ointment formed by combining the components in the main material can effectively treat acute and chronic rhinitis, hypertrophy of nasal turbinates, nasal polyp, nasosinusitis and other nasal symptoms, and has the effects of obvious treatment effect, high cure rate, short treatment time, low treatment cost and stable drug effect.
Detailed Description
The technical solutions in the embodiments of the present application are clearly and completely described below, and it is obvious that the described embodiments are some embodiments of the present application, but not all embodiments. All other embodiments, which can be derived by a person skilled in the art from the embodiments given herein without making any creative effort, shall fall within the protection scope of the present application.
The application provides a rhinitis ointment, which comprises main materials and auxiliary materials, wherein the main materials are smashed and ground into powder and then uniformly mixed, and the auxiliary materials are added into the powder and uniformly prepared into the ointment. The main materials comprise sal ammoniac, magnolia flower, asarum, cocklebur fruit, pangolin scales, cinnabar, sliced plum, indigo naturalis, angelica dahurica, radix aconiti preparata and sodium hydroxide, and the weight percentages of the components in the main materials are as follows: 10% of sal ammoniac, 8% of biond magnolia flower, 2% of asarum, 8% of cocklebur fruit, 5% of pangolin scales, 1% of cinnabar, 3% of sliced plum, 5% of indigo naturalis, 15% of angelica dahurica, 10% of prepared radix aconiti and 10% of sodium hydroxide. The auxiliary material is vaseline, and cooling oil or/and sesame oil can also be added.
Sal ammoniac: has effects in resolving food stagnation, softening hard masses, removing blood stasis, resolving hard mass, removing necrotic tissue, promoting granulation, eliminating phlegm, and promoting urination. It can be used for treating bubo, dysphagia, regurgitation, phlegm-fluid retention, pharyngitis, dysentery, amenorrhea, nebula, polyp, wart, sore, scrofula, carbuncle, and malignant boil.
Flos Magnoliae has effects of dispelling pathogenic wind and cold, dredging meridians and collaterals. The main symptoms are headache, nasosinusitis, stuffy nose and toothache, and the magnolia flower has the functions of astringing to protect nasal mucosa, promoting the absorption of mucosal secretion, relieving inflammation and smoothening nasal cavity.
Asarum: has effects in relieving exterior syndrome, dispelling cold, dispelling pathogenic wind, relieving pain, and inducing resuscitation, and can be used for treating wind-cold exterior syndrome, headache, toothache, rheumatalgia, phlegm retention, cough, and nasal obstruction. Asarum herb is indicated for wind pathogen attacking lung, stuffy nose, nasal sinusitis, headache and nasal discharge, and is combined with Xinyi, Bai Zhi and Xanthium sibiricum.
Fructus xanthil: has effects in dispelling pathogenic wind and cold, relieving nasal obstruction, and dispelling pathogenic wind and dampness, and can be used for treating wind-cold headache, nasosinusitis, watery nasal discharge, rubella pruritus, and rheumatism spasm. For nod Siberian cocklebur fruit, it is indicated for nod , not fragrant and smelly, and whiting fluid and turbid nasal discharge, and often combined with Xinyi, Bai Zhi and Bo He.
The squama Manis has effects of promoting blood circulation, resolving hard mass, dredging collaterals, resolving carbuncle, and resolving hard mass, and can be used for treating amenorrhea, galactostasis, abdominal mass, lymphoid tuberculosis, superficial infection, toxic swelling, rheumatalgia, limb spasm or rigidity.
Cinnabar has the efficacies of clearing away heat and toxic material, relieving palpitation and tranquilization and the like, and is mainly used for treating unsteadiness of heart-mind, palpitation, insomnia, infantile convulsion, epilepsy, sore and carbuncle, swollen sore throat and aphtha of the mouth and tongue.
The Borneolum has effects of inducing resuscitation, clearing heat away, and relieving pain, and can be used for treating apoplexy, trismus, fever, coma, infantile convulsion, phlegm coma, qi block, deafness, pharyngitis, aphtha, otitis media, carbuncle, hemorrhoid, nebula, and enterobiasis.
The Qingdai has the effects of clearing away heat and toxic materials, cooling blood, removing ecchymoses and arresting convulsion, and is mainly used for treating warm-toxin macula, blood heat hematemesis and epistaxis, chest pain, hemoptysis, aphtha, mumps, pharyngitis and infantile convulsion.
Radix Angelicae Dahuricae has effects of promoting blood circulation, expelling pus, promoting granulation and relieving pain, and is used for treating FENG cold, pain and nasal obstruction due to exogenous pathogenic factors, and radix Angelicae Dahuricae is used for treating nose tou pain, and fungal flow and turbid urine nasal discharge, and each is used for ear, magnolia flower and mint.
Prepared Sichuan aconite root, radix Aconiti Preparata has the actions of dispelling wind and removing dampness, warming meridians and alleviating pain, and is mainly used for cold-damp headache, general pain, and pain in the joints, which cannot be flexed, and often combined with Ma Huang, Bai Shao and Huang Qi.
The main materials of the rhinitis ointment mainly comprise magnolia flower, asarum, siberian cocklour fruit and dahurian angelica root, the components are mainly used for treating the nasal disease, and sal ammoniac, prepared common monkshood mother root, indigo naturalis, stir-fried pangolin scales, borneol and the like are added, and the components have the effects of dispelling wind and removing dampness, clearing heat and removing toxicity, eliminating carbuncle and dissipating hard mass, so the rhinitis ointment has the effects of dispelling wind and removing cold, dredging and benefiting orifices, removing food retention and softening hard masses, and activating blood and resolving masses, and is beneficial to treating the nasal disease. When a patient with allergic rhinitis uses the rhinitis ointment, the patient can eliminate the allergen within three days; when the rhinitis ointment is used by patients with hypertrophy of nasal turbinates or nasal polyp, the symptoms of the patients can be eliminated within 15 days; by using the rhinitis ointment for patients with nasosinusitis, the patients can eliminate the symptoms of headache and dizziness caused by nasosinusitis within 7 days.
In summary, the application provides a rhinitis cream, which can be prepared from the main materials according to the weight percentage of the main materials, and has the effects of dispelling wind and cold, dredging the obstruction and benefiting the orifices, removing food retention and softening hard masses, and activating blood and resolving masses. Therefore, the rhinitis ointment has the advantages of obvious treatment effect, high cure rate, short treatment time, low treatment cost and stable drug effect.
It should be noted that, in this document, the terms "comprises," "comprising," or any other variation thereof, are intended to cover a non-exclusive inclusion, such that a process, method, article, or apparatus that comprises a list of elements does not include only those elements but may include other elements not expressly listed or inherent to such process, method, article, or apparatus. Without further limitation, an element defined by the phrase "comprising an … …" does not exclude the presence of other like elements in a process, method, article, or apparatus that comprises the element.
While the present application has been described with reference to exemplary embodiments thereof, it is to be understood that the present application is not limited to the disclosed embodiments, which are presented by way of illustration rather than of limitation, and that various modifications may be made by those skilled in the art without departing from the spirit and scope of the present application as defined by the appended claims.
Claims (3)
1. The rhinitis ointment comprises main materials and auxiliary materials, and is characterized in that the main materials comprise salmiacum, biond magnolia flower, asarum, cocklebur fruit, pangolin scales, cinnabar, borneol, indigo naturalis, angelica dahurica, radix aconiti preparata and sodium hydroxide, wherein the main materials comprise the following components in percentage by weight: 10% of sal ammoniac, 8% of biond magnolia flower, 2% of asarum, 8% of cocklebur fruit, 5% of pangolin scales, 1% of cinnabar, 3% of sliced plum, 5% of indigo naturalis, 15% of angelica dahurica, 10% of prepared radix aconiti and 10% of sodium hydroxide, and the auxiliary materials comprise vaseline.
2. The rhinitis ointment according to claim 1, wherein the main material is smashed and ground into powder, then mixed evenly, and the auxiliary material is added into the powder to be prepared into ointment evenly.
3. The rhinitis cream of claim 1, wherein the adjuvant further comprises cooling oil.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201911088094.1A CN110742930A (en) | 2019-11-08 | 2019-11-08 | Rhinitis ointment |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201911088094.1A CN110742930A (en) | 2019-11-08 | 2019-11-08 | Rhinitis ointment |
Publications (1)
Publication Number | Publication Date |
---|---|
CN110742930A true CN110742930A (en) | 2020-02-04 |
Family
ID=69282689
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201911088094.1A Pending CN110742930A (en) | 2019-11-08 | 2019-11-08 | Rhinitis ointment |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN110742930A (en) |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109223898A (en) * | 2018-12-13 | 2019-01-18 | 胡献军 | A kind for the treatment of of rhinitis ointment and preparation method thereof |
-
2019
- 2019-11-08 CN CN201911088094.1A patent/CN110742930A/en active Pending
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109223898A (en) * | 2018-12-13 | 2019-01-18 | 胡献军 | A kind for the treatment of of rhinitis ointment and preparation method thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101703597B (en) | Medicament for treating rhinitis | |
CN107050195A (en) | A kind of mouth mask filter core humidification decoction and preparation method thereof | |
CN102688383A (en) | Traditional Chinese medicine composite for treating body surface ulcer or fester | |
CN111067935A (en) | Rhinitis medicine and preparation method thereof | |
US20200316153A1 (en) | Externally-used traditional chinese medicine preparation for treating rhinitis, and preparation method therefor | |
CN103100016B (en) | Chinese medicament for treating pruritus cutanea | |
CN107753631A (en) | A kind of Rhinitis treating medicinal cream of antibacterial sterilization and preparation method thereof | |
CN104524213A (en) | Plaster for treating bronchiectasis | |
CN104587033B (en) | A kind of Nano Silver rhinitis ointment | |
CN110742930A (en) | Rhinitis ointment | |
CN104587150A (en) | Traditional Chinese medicine for treating rhinitis | |
CN104107376A (en) | Composition and preparation method of external anti-inflammatory drug | |
CN106983832A (en) | A kind of skin disinfectant and preparation method thereof | |
CN1053816C (en) | Oil agent for curing rhinitis | |
CN104547128A (en) | Medicine for treating rhinitis | |
CN105395587A (en) | Traditional Chinese medicine reagent used for treating nose problems and preparation method thereof | |
CN104857075A (en) | Traditional Chinese medicinal composition for treating rhinitis, nasal polyp and sphagitis, and preparation method thereof | |
CN105213902A (en) | A kind of Chinese medicine decoction for the treatment of leptospirosis and preparation method thereof | |
CN101628037B (en) | Cassia twig and honeysuckle powder used for influenza | |
CN1634467A (en) | Compound collunarium oil and preparation method thereof | |
CN104383217A (en) | Traditional Chinese medicine composition for treating dermatophytosis and preparation method of traditional Chinese medicine composition | |
CN107496616A (en) | A kind of Chinese medicine for treating otitis media purulenta chronica | |
CN106902154A (en) | A kind of ointment for treating rhinitis | |
CN107334817A (en) | A kind of Chinese medicine for treating nasosinusitis | |
CN105920354A (en) | Throat inhalant for treating bronchiectasia |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WD01 | Invention patent application deemed withdrawn after publication | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20200204 |